Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil

BACKGROUND: Long-acting insulin analogues for type 1 diabetes (T1D) treatment have been available on the Brazilian market since 2002. However, the population cannot access the analogues through the public health system. OBJECTIVE: To estimate the incremental budget impact of long-acting insulin anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Laranjeira, Fernanda O, da Silva, Everton Nunes, Pereira, Maurício G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132224/
https://www.ncbi.nlm.nih.gov/pubmed/27907034
http://dx.doi.org/10.1371/journal.pone.0167039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132224/
https://www.ncbi.nlm.nih.gov/pubmed/27907034
http://dx.doi.org/10.1371/journal.pone.0167039

Ejemplares similares